1. Home
  2. QUBT vs DMRA Comparison

QUBT vs DMRA Comparison

Compare QUBT & DMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quantum Computing Inc.

QUBT

Quantum Computing Inc.

HOLD

Current Price

$8.57

Market Cap

1.7B

Sector

Technology

ML Signal

HOLD

DMRA

Damora Therapeutics Inc. Common Stock

N/A

Current Price

$20.75

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
QUBT
DMRA
Founded
2001
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
QUBT
DMRA
Price
$8.57
$20.75
Analyst Decision
Buy
Buy
Analyst Count
6
2
Target Price
$17.50
★ $43.00
AVG Volume (30 Days)
★ 6.0M
632.6K
Earning Date
05-13-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
84.93
★ 121.48
EPS
★ N/A
N/A
Revenue
★ $682,000.00
N/A
Revenue This Year
$3,210.56
N/A
Revenue Next Year
$51.26
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 82.84
N/A
52 Week Low
$6.18
$16.50
52 Week High
$25.84
$34.89

Technical Indicators

Market Signals
Indicator
QUBT
DMRA
Relative Strength Index (RSI) 52.30 27.75
Support Level $7.72 $18.59
Resistance Level $9.25 $27.40
Average True Range (ATR) 0.37 1.90
MACD 0.10 -0.55
Stochastic Oscillator 48.36 9.29

Price Performance

Historical Comparison
QUBT
DMRA

About QUBT Quantum Computing Inc.

Quantum Computing Inc is an integrated photonics and non-linear quantum optics company to develop and deliver machines for quantum computing, reservoir computing, and remote sensing, imaging, and cybersecurity applications based on patented and proprietary photonics technology. Its products are designed to operate at room temperature and low power at an affordable cost. The Company's portfolio of core technologies and products offers capabilities in the areas of high-performance computing, artificial intelligence, and cybersecurity, as well as remote sensing applications.

About DMRA Damora Therapeutics Inc. Common Stock

Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.

Share on Social Networks: